This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Google Scholar Articles by Herndon, C. M. Articles by Zimmerman, E. PubMed PubMed Citation Articles by Herndon, C. M. Articles by Zimmerman, E. Social Bookmarking                   What's this?

High-Dose Propofol Drip for Palliative Sedation: A Case Report

Southern Illinois University School of Pharmacy

^* To whom correspondence should be addressed. E-mail: cherndo{at}siue.edu.

	Abstract

Oftentimes, patients at the end of life may present with challenging symptoms refractory to conventional therapies. Agitation and terminal restlessness, 2 common symptoms encountered in the hospice population, are frequently managed using benzodiazepines or typical antipsychotics. In clinical scenarios that either preclude their use or in which they prove ineffective, alternative pharmacotherapy must be considered. Propofol, a sedative-hypnotic unrelated to any other class of drug, may provide palliation of agitation and terminal restlessness refractory to benzodiazepines or antipsychotics. Here, the authors present a hospice patient admitted to the general medical floor of a small community hospital for pain and symptom management. A history of polysubstance abuse contributes to rapidly escalating doses of opioids and midazolam. Failure to control her symptoms resulted in the initiation and successful titration of propofol.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?